Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)739-741
Number of pages3
JournalBritish Journal of Haematology
Volume182
Issue number5
DOIs
Publication statusPublished - Sep 2018

Keywords

  • Bortezomib
  • Multiple myeloma
  • Proteasome inhibitors

Cite this

@article{36e5d74b995a45ec8378bd1c055d05f7,
title = "Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma",
keywords = "Bortezomib, Multiple myeloma, Proteasome inhibitors",
author = "Adrian Chee and Low, {Michael S.} and Shahla Vilcassim and Gregory, {Gareth P.} and Michael Gilbertson and Sumita Ratnasingam and George Grigoriadis and Fedele, {Pasquale L.}",
year = "2018",
month = "9",
doi = "10.1111/bjh.14871",
language = "English",
volume = "182",
pages = "739--741",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons",
number = "5",

}

TY - JOUR

T1 - Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma

AU - Chee, Adrian

AU - Low, Michael S.

AU - Vilcassim, Shahla

AU - Gregory, Gareth P.

AU - Gilbertson, Michael

AU - Ratnasingam, Sumita

AU - Grigoriadis, George

AU - Fedele, Pasquale L.

PY - 2018/9

Y1 - 2018/9

KW - Bortezomib

KW - Multiple myeloma

KW - Proteasome inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85028671905&partnerID=8YFLogxK

U2 - 10.1111/bjh.14871

DO - 10.1111/bjh.14871

M3 - Article

VL - 182

SP - 739

EP - 741

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -